Navigation Links
DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies

The Drug Information (DIA) will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, 2010 in Washington, DC.

Horsham, PA (Vocus) November 19, 2009 -- The Drug Information (DIA) will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, 2010 in Washington, DC.

This comprehensive three-day program will discuss the current complexities and controversies in pharmacovigilance and risk management throughout all phases of development and marketed use, how to optimally utilize epidemiological, clinical pharmacological and other techniques, risk management strategies, and how to create an effective organizational “system.” Session topics will include:

  • Latest international regulatory developments
  • How to generate and assess critical safety data during development
  • Compliance with clinical safety and post-marketing pharmacovigilance regulatory requirements in an evolving global environment
  • Recent multinational initiatives under the International Conference on Harmonization (ICH) and Council for International Organizations of Medical Sciences (CIOMS) on Drug Safety Update Reports (DSURs) in premarketing clinical trial safety
  • New approaches to risk management, risk communication, labeling and packaging to optimize medical product benefit while minimizing preventable harm

“Robust drug safety systems and processes and thorough ongoing safety surveillance are more critical than ever in the development and evaluation of the safe use of marketed medicinal products,” says,
Program Committee Member Mariette Boerstoel-Streefland, MD, MBA, MS(epi), Executive Director, Pharmacovigilance/Risk Management, Forest Research Institute, Forest Laboratories Inc. “This conference will provide safety professionals with the latest pharmacovigilance regulatory advances and state-of-the-art risk management strategies."

Pre-conference tutorials on January 9 will focus on:

  • Signal Detection, Case Assessment and Data Mining in Pharmacovigilance: Current State of the Art
  • Periodic Safety Update Reports (PSUR): A Guide to the Construction and Analysis of PSURs, ASRs, and DSURs
  • Applied Epidemiology Techniques for Pharmacovigilance Risk Management
  • Applying MedDRA® in Clinical Safety, Pharmacovigilance and Labeling
  • Pharmacovigilance and Risk Management Planning

Register for the 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies.

About the Drug Information Association (DIA)
A non-profit, neutral, multidisciplinary, global, member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit or call 215-442-6100.

Joe Krasowski


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Respirators and H1N1 Information Distributed to Registered Nurses at Sacred Heart Medical Center Out of Concern for Nurse and Patient Safety
2. National Patient Safety Foundation Supports Mandatory Flu Vaccinations for Healthcare Workers
3. Houston Dermatologists to Round Up for Sun Safety at World-Class LPGA Tour Championship
4. Dairy Groups Urge Senators to Include Raw Milk Facilities in Food Safety Regulations
5. Walking hazard: Cell-phone use -- but not music -- reduces pedestrian safety
6. XOLAIR Safety Study Continues to 2012 Despite Increased Rate of Occurrence of Heart Problems, Onder Law Firm Offers Free XOLAIR Case Review
7. FDA Questions Safety of Caffeinated Alcoholic Drinks
8. Centerplate and the Capital Improvement Board Investigating Food Safety Violations at Lucas Oil Stadium to Ensure Highest Standards Achieved and Operational Excellence
9. New Polls, Reports Highlight The Need To Update The U.S. Food Safety System And To Make Our Food Safe For The Holidays
10. New Research Center to Focus on Cardiac Safety and Innovation
11. New research center to focus on cardiac safety and innovation
Post Your Comments:
Related Image:
DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the ... 2016 Building Better Radiology Marketing Programs meeting will showcase some of ... 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session on ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you stop ... not only fulfilling the needs of advisers and clients but going above and ... providing top-tier customer service. However, there's always room for improvement, which is why ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... the largest, most successful and prominent nonprofit healthcare organizations in the country. They ... involvement with various organizations, and helped advance the healthcare industry as a whole ...
(Date:11/27/2015)... ... 2015 , ... Indosoft Inc., developer and distributor of the ... LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making the ... a version of Asterisk that will receive not only security fixes, but feature ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD ... for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family physicians ... directly from their electronic medical record (EMR) without the need for redundant patient ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: